Healthpeak Properties stock costs EUR 16.97, up 1.41 percent on Nasdaq

Published on 10/15/2026 at 19:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

On October 13, 2026 Barclays set a USD 21.00 target. Healthpeak Properties stock costs EUR 16.97 on October 15, 2026, up 1.41 percent on Nasdaq.

Target and quarterly revenue

Barclays lowered its Healthpeak target to USD 21.00 on October 13, 2026.
Second-quarter revenue reached USD 771.58 million, up 11.10 percent year over year.
Healthpeak Properties stock costs EUR 16.97 at Lang & Schwarz on October 15, 2026 at 7:32 p.m. CEST, up 1.41 percent versus the Nasdaq prior close of October 14, 2026.
Healthpeak trades at a P/E ratio of 54.41 with a market capitalization of USD 13.1 billion.

Modernes Ambulanzgebäude von Healthpeak Properties US42226K1051 bei goldenem Abendlicht — Healthpeak Properties US42226K1051 zeigt modernes Ambulanzgebäude mit Glasfassade bei goldenem Abendlicht auf gepflegtem Campus, Illustration mit AI erstellt.

Barclays lowered its price target for Healthpeak Properties to USD 21.00 from USD 24.00 on October 13, 2026, while retaining an Equal Weight rating, Markets Insider reported. Against the USD 19.00 Nasdaq price, the new target is 10.53 percent higher. Healthpeak Properties stock was trading at EUR 16.97 at Lang & Schwarz on October 15, 2026 at 7:32 p.m. CEST, up 1.41 percent versus the Nasdaq prior close of October 14, 2026.

Revenue sets the operating backdrop

Healthpeak reported USD 771.58 million in second-quarter 2026 revenue, an 11.10 percent increase from USD 694.30 million a year earlier. Quarterly net income was USD 63.24 million and diluted earnings per share were USD 0.08 for the period ended June 30, 2026. The revenue comparison and quarterly figures were reported by MarketBeat.

Stock remains below its yearly high

The Nasdaq quote stood at USD 19.00 at 1:35 p.m. ET on October 15, 2026, with a session change of USD 0.27. Healthpeak's 52-week range was USD 15.70 to USD 22.95, placing the latest Nasdaq price 17.21 percent below the high. Trading volume reached 2,096,565 shares against an average of 5,506,307.

Valuation meets the next date

Healthpeak had a market capitalization of USD 13.1 billion and a P/E ratio of 54.41 as of October 15, 2026. The trailing dividend yield was 0.06 percent. Healthpeak is scheduled to publish third-quarter 2026 results after the New York Stock Exchange close on November 2, 2026, according to its Healthpeak Properties investor release.

Comparison with peers

DOC (NYSE, USD): plus 1.41 percent, P/E 54.41, market capitalization USD 13.1 billion.
Welltower (NYSE, USD): plus 0.93 percent, P/E 124.17, market capitalization USD 168.8 billion.
Healthcare Realty Trust (NYSE, USD): plus 1.38 percent, P/E minus 65.90, market capitalization USD 6.0 billion.

After-hours price and valuation

The euro quote places the stock above the Nasdaq prior close in the German investor perspective, while the USD 21.00 Barclays target remains the clearest near-term analyst reference. The next scheduled company date is November 2, 2026.

Healthpeak Properties was trading at EUR 16.97 at Lang & Schwarz on October 15, 2026 at 7:32 p.m. CEST, up 1.41 percent versus the Nasdaq prior close of October 14, 2026.

The further course of trading is shown by the continuously updated real-time quote of Healthpeak Properties stock.